Quercetin but not quercitrin ameliorates tumor necrosis factor-alpha-induced insulin resistance in C2C12 skeletal muscle cells

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 5, 2013, Pages 788-795

  Dai, Xiaoqian ^a   Ding, Ye ^a   Zhang, Zhaofeng ^a   Cai, Xiaxia ^a   Bao, Lei ^a   Li, Yong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

AMP activated protein kinase; Inflammation; Insulin resistance; Quercetin; Skeletal muscle cell

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; QUERCETIN; QUERCITRIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVATION; GLUCOSE TRANSPORT; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MUSCLE CELL; NONHUMAN; OPTICAL DENSITY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MICE; MUSCLE FIBERS, SKELETAL; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876935243     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00947     Document Type: Article

References (49)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature, 444, 860-867 (2006).
2. Wentworth JM, Fourlanos S, Harrison LC. Reappraising the stereotypes of diabetes in the modern diabetogenic environment. Nat. Rev. Endocrinol., 5, 483-489 (2009).
3. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56, 1761-1772 (2007).
4. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes, 54, 2939-2945 (2005).
5. Hommelberg PP, Langen RC, Schols AM, Mensink RP, Plat J. Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention? Curr. Opin. Clin. Nutr. Metab. Care, 13, 647-655 (2010).
6. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes, 30, 1000-1007 (1981).
7. Hwang JT, Kwon DY, Yoon SH. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotechnol., 26, 17-22 (2009).
8. Tomás E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y, Ruderman NB. Hyperglycemia and insulin resistance: possible mechanisms. Ann. N. Y. Acad. Sci., 967, 43-51 (2002).
9. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell, 129, 1261-1274 (2007).
10. Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Görgün CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab., 4, 465-474 (2006).
11. Fujii N, Jessen N, Goodyear LJ. AMP-activated protein kinase and the regulation of glucose transport. Am. J. Physiol. Endocrinol. Metab., 291, E867-E877 (2006).
12. Beck Jørgensen S, O'Neill HM, Hewitt K, Kemp BE, Steinberg GR. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia, 52, 2395-2404 (2009).
13. Kraegen EW, Bruce C, Hegarty BD, Ye JM, Turner N, Cooney G. AMP-activated protein kinase and muscle insulin resistance. Front. Biosci., 14, 4658-4672 (2009).
14. Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem., 49, 3106-3112 (2001).
15. Zunino S. Type 2 diabetes and glycemic response to grapes or grape products. J. Nutr., 139, 1794S-1800S (2009).
16. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S. Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-κB pathway. Nutr. Cancer, 64, 588-598 (2012).
17. Zhang ZJ, Cheang LC, Wang MW, Lee SM. Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int. J. Mol. Med., 27, 195-203 (2011).
18. Liu H, Zhang L, Lu S. Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats. Molecules, 17, 4281-4291 (2012).
19. Eid HM, Martineau LC, Saleem A, Muhammad A, Vallerand D, Benhaddou-Andaloussi A, Nistor L, Afshar A, Arnason JT, Haddad PS. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol. Nutr. Food Res., 54, 991-1003 (2010).
20. Babujanarthanam R, Kavitha P, Pandian MR. Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam. Clin. Pharmacol., 24, 357-364 (2010).
21. Cheng FC, Shen SC, Wu JS. Effect of guava (Psidium guajava L.) leaf extract on glucose uptake in rat hepatocytes. J. Food Sci., 74, H132-H138 (2009).
22. Cho JM, Chang SY, Kim DB, Needs PW, Jo YH, Kim MJ. Effects of physiological quercetin metabolites on interleukin-1β-induced inducible NOS expression. J. Nutr. Biochem., 23, 1394-1402 (2012).
23. Lee ES, Uhm KO, Lee YM, Han M, Lee M, Park JM, Suh PG, Park SH, Kim HS. CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells. Biochem. Biophys. Res. Commun., 361, 854-858 (2007).
24. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA, 288, 2579-2588 (2002).
25. Lee SH, Kang SM, Ko SC, Lee DH, Jeon YJ. Octaphlorethol A, a novel phenolic compound isolated from a brown alga, Ishige foliacea, increases glucose transporter 4-mediated glucose uptake in skeletal muscle cells. Biochem. Biophys. Res. Commun., 420, 576-581 (2012).
26. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr., 137, 2405-2411 (2007).
27. Gruzman A, Babai G, Sasson S. Adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: A review on metabolic, pharmacological and chemical considerations. Rev. Diabet. Stud., 6, 13-36 (2009).
28. Shen JZ, Ma LN, Han Y, Liu JX, Yang WQ, Chen L, Liu Y, Hu Y, Jin MW. Pentamethylquercetin generates beneficial effects in monosodium glutamate-induced obese mice and C2C12 myotubes by activating AMP-activated protein kinase. Diabetologia, 55, 1836-1846 (2012).
29. Anhê GF, Okamoto MM, Kinote A, Sollon C, Lellis-Santos C, Anhê FF, Lima GA, Hirabara SM, Velloso LA, Bordin S, Machado UF. Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. Eur. J. Pharmacol., 689, 285-293 (2012).
30. Nomura M, Takahashi T, Nagata N, Tsutsumi K, Kobayashi S, Akiba T, Yokogawa K, Moritani S, Miyamoto K. Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells. Biol. Pharm. Bull., 31, 1403-1409 (2008).
31. Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem. J., 386, 471-478 (2005).
32. Koch CE, Ganjam GK, Steger J, Legler K, Stöhr S, Schumacher D, Hoggard N, Heldmaier G, Tups A. The dietary flavonoids naringenin and quercetin acutely impair glucose metabolism in rodents possibly via inhibition of hypothalamic insulin signalling. Br. J. Nutr., 6, 1040-1051 (2013).
33. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 135C, 357-364 (2003).
34. Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes, 50, 1102-1109 (2001).
35. Yoon JH, Song P, Jang JH, Kim DK, Choi S, Kim J, Ghim J, Kim D, Park S, Lee H, Kwak D, Yea K, Hwang D, Suh PG, Ryu SH. Proteomic analysis of tumor necrosis factor-alpha (TNF-α)-induced L6 myotube secretome reveals novel TNF-α-dependent myokines in diabetic skeletal muscle. J. Proteome Res., 10, 5315-5325 (2011).
36. Bhavsar SK, Föller M, Gu S, Vir S, Shah MB, Bhutani KK, Santani DD, Lang F. Involvement of the PI3K/AKT pathway in the hypoglycemic effects of saponins from Helicteres isora. J. Ethnopharmacol., 126, 386-396 (2009).
37. Kim MK, Jung HS, Yoon CS, Ko JH, Chun HJ, Kim TK, Kwon MJ, Lee SH, Koh KS, Rhee BD, Park JH. EGCG and quercetin protected INS-1 cells in oxidative stress via different mechanisms. Front Biosci (Elite Ed), 2, 810-817 (2010).
38. Fisher JS. Potential role of the AMP-activated protein kinase in regulation of insulin action. Cellscience, 2, 68-81 (2006).
39. Cartee GD, Wojtaszewski JF. Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl. Physiol. Nutr. Metab., 32, 557-566 (2007).
40. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J. Cell. Biochem., 92, 285-295 (2004).
41. Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, Katsarou-Katsari A, Antoniou C, Theoharides TC. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS ONE, 7, e33805 (2012).
42. Ying B, Yang T, Song X, Hu X, Fan H, Lu X, Chen L, Cheng D, Wang T, Liu D, Xu D, Wei Y, Wen F. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol. Biol. Rep., 36, 1825-1832 (2009).
43. Rangan GK, Wang Y, Harris DC. Dietary quercetin augments activator protein-1 and does not reduce nuclear factor-kappa B in the renal cortex of rats with established chronic glomerular disease. Nephron, 90, 313-319 (2002).
44. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resis tance. J. Clin. Invest., 116, 1793-1801 (2006).
45. Kubota S, Ozawa Y, Kurihara T, Sasaki M, Yuki K, Miyake S, Noda K, Ishida S, Tsubota K. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest. Ophthalmol. Vis. Sci., 52, 9142-9148 (2011).
46. Yang Z, Kahn BB, Shi H, Xue BZ. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem., 285, 19051-19059 (2010).
47. Darville MI, Eizirik DL. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia, 41, 1101-1108 (1998).
48. Kapur S, Bédard S, Marcotte B, Côté CH, Marette A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes, 46, 1691-1700 (1997).
49. Sugita H, Fujimoto M, Yasukawa T, Shimizu N, Sugita M, Yasuhara S, Martyn JA, Kaneki M. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J. Biol. Chem., 280, 14203-14211 (2005).